Statements included herein that are not historical facts, including without limitation statements concerning future strategy, plans, objectives, expectations and intentions, projected financial results, liquidity, growth and prospects, are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Millicom's results could be materially adversely affected. In particular, t ...

Safe harbor & Non-gaap measures Forward-Looking Statements This presentation contains statements by Celsius Holdings, Inc. ("Celsius Holdings", "we", "us", "our" or the "Company") that are not historical facts and are considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may address, among other things, our prospects, plans, business strategy and expected financial and operational results. You can identify these sta ...

NASDAQ: HBIO 3Q25 Earnings Presentation John Duke, President & CEO Mark Frost, Interim CFO & Treasurer November 6, 2025 Forward-Looking Statements and Non-GAAP Financial Information Forward-Looking Statements This document contains forward-looking statements within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995. Forward- looking statements may be identified by the use of words such as "may," "will," "expect," "plan," "anticipate," "estimate," "inte ...

Second Quarter Fiscal 2026 Results November 6, 2025 © 2025 Haemonetics Corporation Q2 Fiscal 2026 Conference Call Detail Conference call will take place at 8:00 a.m. ET on November 6, 2025, and can be accessed via live webcast: Link or teleconference: Link The financial release, accompanying slides, and a replay of the conference call (beginning at 11:00 AM ET) are available online at www.haemonetics.com. Conference call speakers: Chris Simon President & CEO James D'Arecca EVP, Chief Financial Officer Olga ...

Q3 2025 Financial Performance - Revenue increased to $684 million in Q3 2025 compared to $708 million in Q3 2024[42] - Adjusted EBITDA increased by 32% to $125 million in Q3 2025 from $95 million in Q3 2024[13, 43] - Recurring revenue increased by 5% to $425 million in Q3 2025 from $405 million in Q3 2024[13] - Non-GAAP Diluted EPS was $031 in Q3 2025, compared to $001 in Q3 2024[13, 45] YTD 2025 Financial Performance - Recurring revenue increased by 4% to $1254 million YTD 2025 from $1211 million YTD 2024[26] - Adjusted EBITDA increased by 20% to $295 million YTD 2025 from $237 million YTD 2024[26] Debt and Cash Flow - Total debt as of September 30, 2025, was $1105 million[18] - Net debt was $823 million as of September 30, 2025[18, 48] - Adjusted Net Leverage Ratio is 20x, calculated as net debt divided by the last twelve months Adjusted EBITDA[18, 48] FY 2025 Outlook - Total revenue is projected to be between $2650 million and $2670 million[20] - Adjusted EBITDA is projected to be between $420 million and $435 million[20]

Third Quarter 2025 Financial Results and Recent Corporate Updates November 2025 Forward-Looking Statements This presentation contains forward-looking statements, including statements relating to our strategy and plans; potential of and expectations for our business, commercial products, and pipeline programs; our goals, objectives, and priorities and our expectations under our growth strategy (including our expectations regarding our commercial products and launches, clinical stage products, revenue growth ...

3 rd Quarter 2025 Results November 6, 2025 Parth Mehrotra, CEO David Mountcastle, CFO Use of Non-GAAP Financial Information In order to provide investors with greater insight, promote transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making, the Company supplements its condensed consolidated financial statements presented on a GAAP basis herein with certain non-GAAP financial information, including: Care Margin; Plat ...

LANTHEUS Lantheus Third Quarter 2025 Results Financial Update Closing Remarks Q&A SPEAKERS NOVEMBER 6, 2025 FIND. FIGHT. FOLLOW. @ 2025 Lantheus. All rights reserved. Agenda Highlights and Business Update Brian Markison CEO Bob Marshall CFO and Treasurer Mark Kinarney Vice President, Investor Relations LANTHEUS @ 2025 Lantheus. All rights reserved. 2 Safe Harbor Statements Cautionary Statement Regarding Forward-Looking Statements This document cochina frequencel cological of the memping of the Pirinte Beach ...

Second Quarter FY2026 Results November 6, 2025 Disclaimer General All references in this presentation to the "Company", "Lightspeed", "us" or "we" are to Lightspeed Commerce Inc. All references in this presentation to dollars, "$" or "US$" are to United States dollars, and all references to Canadian dollars and "C$" are to Canadian dollars. Cautionary Note Regarding Forward-Looking Information This presentation contains "forward-looking information" and "forward-looking statements" (collectively, "forward-l ...

Q3 2025 Investor Presentation Forward-Looking Statements Certain statements in this presentation are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, in ...